{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:10:05Z","timestamp":1791425405898,"version":"4.3.3"},"reference-count":32,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The T-cell leukemia\/lymphoma 1 (TCL1) oncogene is a target of chromosomal translocations and inversions at 14q31.2, and its rearrangement in T cells causes T-cell prolymphocytic leukemias. TCL1 dysregulation in B cells is responsible for the development of an aggressive form of chronic lymphocytic leukemia (CLL), the most common human leukemia. We have investigated the mechanisms underlying the oncogenic functions of Tcl1 protein using a mass spectrometry approach and have identified Atm (ataxia-telangiectasia mutated) as a candidate Tcl1-interacting protein. The Tcl1-Atm complex formation was validated by coimmunoprecipitation experiments. Importantly, we show that the association of Atm with Tcl1 leads to enhanced I\u03baB\u03b1 phosphorylation and ubiquitination and subsequent activation of the NF-\u03baB pathway. Our findings reveal functional cross-talk between Atm and Tcl1 and provide evidence for a novel pathway that could be targeted in leukemias and lymphomas.<\/jats:p>","DOI":"10.1182\/blood-2011-08-374561","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T08:48:04Z","timestamp":1320742084000},"page":"180-187","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Tcl1 interacts with Atm and enhances NF-\u03baB activation in hematologic malignancies"],"prefix":"10.1182","volume":"119","author":[{"given":"Eugenio","family":"Gaudio","sequence":"first","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"},{"name":"Department of Experimental and Clinical Medicine, University Magna Gr\u00e6cia of Catanzaro, Catanzaro, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Spizzo","sequence":"additional","affiliation":[{"name":"Division of Experimental Oncology 2 Centro di Riferimento Oncologico, Aviano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paduano","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University Magna Gr\u00e6cia of Catanzaro, Catanzaro, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Efanov","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Palamarchuk","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Leber","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kaou","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zanesi","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bottoni","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Costinean","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at San Diego, La Jolla, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at San Diego, La Jolla, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami I.","family":"Aqeilan","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"},{"name":"Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research, Hebrew University, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Pekarsky","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trapasso","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"},{"name":"Department of Experimental and Clinical Medicine, University Magna Gr\u00e6cia of Catanzaro, Catanzaro, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111719300635100_B1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1073\/pnas.96.6.2949","article-title":"Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.","volume":"96","author":"Pekarsky","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2019111719300635100_B2","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1073\/pnas.182412399","article-title":"TCL1 participates in early embryonic development and is overexpressed in human seminomas.","volume":"99","author":"Narducci","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"2019111719300635100_B3","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":"Identification of the TCL1 gene involved in T-cell malignancies.","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111719300635100_B4","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V87.5.1923.1923","article-title":"Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.","volume":"87","author":"Madani","year":"1996","journal-title":"Blood"},{"issue":"8","key":"2019111719300635100_B5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.onc.1201246","article-title":"The murine Tcl1 oncogene: embryonic and lymphoid cell expression.","volume":"15","author":"Narducci","year":"1997","journal-title":"Oncogene"},{"issue":"24","key":"2019111719300635100_B6","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res"},{"issue":"10","key":"2019111719300635100_B7","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2019111719300635100_B8","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2019111719300635100_B9","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","article-title":"Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.","volume":"97","author":"Pekarsky","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"2019111719300635100_B10","doi-asserted-by":"crossref","first-page":"19643","DOI":"10.1073\/pnas.0810965105","article-title":"Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.","volume":"105","author":"Pekarsky","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2019111719300635100_B11","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1158\/0008-5472.CAN-09-4411","article-title":"Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.","volume":"70","author":"Hofbauer","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"2019111719300635100_B12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity.","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2019111719300635100_B13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molcel.2010.08.019","article-title":"AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling.","volume":"39","author":"Sherman","year":"2010","journal-title":"Mol Cell"},{"issue":"6","key":"2019111719300635100_B14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.bjc.6601213","article-title":"Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.","volume":"89","author":"Gabellini","year":"2003","journal-title":"Br J Cancer"},{"issue":"3","key":"2019111719300635100_B15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35043058","article-title":"The many substrates and functions of ATM.","volume":"1","author":"Kastan","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2019111719300635100_B16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.cdd.4401877","article-title":"NF-kappaB and IKK as therapeutic targets in cancer.","volume":"13","author":"Kim","year":"2006","journal-title":"Cell Death Differ"},{"issue":"1","key":"2019111719300635100_B17","first-page":"24","article-title":"ATM gene product phosphorylates I kappa B-alpha.","volume":"57","author":"Jung","year":"1997","journal-title":"Cancer Res"},{"issue":"8","key":"2019111719300635100_B18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/onc.2008.457","article-title":"ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.","volume":"28","author":"Grosjean-Raillard","year":"2009","journal-title":"Oncogene"},{"issue":"5764","key":"2019111719300635100_B19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1121513","article-title":"Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.","volume":"311","author":"Wu","year":"2006","journal-title":"Science"},{"issue":"13","key":"2019111719300635100_B20","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1074\/jbc.M109.095208","article-title":"Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM\/NEMO-related pathway.","volume":"285","author":"Rosato","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111719300635100_B21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling.","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"2","key":"2019111719300635100_B22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","article-title":"The protooncogene TCL1 is an Akt kinase coactivator.","volume":"6","author":"Laine","year":"2000","journal-title":"Mol Cell"},{"issue":"6","key":"2019111719300635100_B23","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood.V86.6.2358.bloodjournal8662358","article-title":"TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.","volume":"86","author":"Narducci","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2019111719300635100_B24","first-page":"379","article-title":"Expression of either the TCL1 oncogenes, or transcripts from its homologue MTCP1\/c6.1B, in leukemic and non-leukemic T cells from ataxia telangiectasia patients.","volume":"12","author":"Thick","year":"1996","journal-title":"Oncogene"},{"issue":"7","key":"2019111719300635100_B25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/bi00122a004","article-title":"Neocarzinostatin- mediated DNA damage in a model AGT.ACT site: mechanistic studies of thiol-sensitive partitioning of C4\u2032 DNA damage products.","volume":"31","author":"Dedon","year":"1992","journal-title":"Biochemistry"},{"issue":"9","key":"2019111719300635100_B26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cyto.a.20426","article-title":"Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.","volume":"71","author":"Tanaka","year":"2007","journal-title":"Cytometry A"},{"issue":"5","key":"2019111719300635100_B27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/MCB.22.5.1513-1525.2002","article-title":"Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.","volume":"22","author":"K\u00fcnstle","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2019111719300635100_B28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jcp.22105","article-title":"Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.","volume":"223","author":"Shifera","year":"2010","journal-title":"J Cell Physiol"},{"issue":"1","key":"2019111719300635100_B29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.emboj.7600501","article-title":"NF-kappaB\/Egr-1\/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death.","volume":"24","author":"Thyss","year":"2005","journal-title":"EMBO J"},{"issue":"5","key":"2019111719300635100_B30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jcb.21147","article-title":"Animal models for chronic lymphocytic leukemia.","volume":"100","author":"Pekarsky","year":"2007","journal-title":"J Cell Biochem"},{"issue":"1","key":"2019111719300635100_B31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2007-07-101519","article-title":"High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.","volume":"111","author":"Herling","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111719300635100_B32","doi-asserted-by":"crossref","first-page":"e6567","DOI":"10.1371\/journal.pone.0006567","article-title":"The TCL1A oncoprotein interacts directly with the NF-KappaB inhibitor IkappaB.","volume":"4","author":"Ropars","year":"2009","journal-title":"PloS One"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/1\/180\/1347442\/zh800112000180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/1\/180\/1347442\/zh800112000180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T14:25:24Z","timestamp":1713104724000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/1\/180\/125699\/Tcl1-interacts-with-Atm-and-enhances-NF%CE%BAB"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-08-374561","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,5]]}}}